The Focal Therapy Clinic

08/01/2026

welcoming the continual advancement of precision diagnostics for prostate cancer

Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer IRVINE, CA – January XX, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a leading precision diagno...

07/01/2026

Clarity and good humour on a touchy but important topic

06/01/2026

"Following the improvement of survivorship rates in male patients, an andrological assessment should always be included over the follow-up of cancer survivors"

Male cancer survivors may develop sexual dysfunction (SD) even many years after recovery from cancer. We aimed to evaluate the prevalence of and the clinical characteristics of cancer survivors among men seeking medical help for SD (any) in the real-life setting of an andrological tertiary-referral....

05/01/2026

Personalised care is our hallmark

Learn how focal therapy patients are monitored for long-term safety through PSA tests, MRI scans, biopsies, and follow-up care. Book a consultation today.

04/01/2026

A nationwide survey of prostate MRI practices in the UK revealed the universal adoption of pre-biopsy MRI across all NHS trusts, with 73.1% using multiparametric MRI protocols. However, significant variations in staging protocols persisted between university teaching hospitals and other settings.

A new survey of UK radiologists finds that 100% of NHS trusts have now used pre-biopsy MRI, although variations persist in patient preparation and staging.

24/12/2025

wishing all our followers & supporters a very Happy Christmas & New Year

23/12/2025

2025 has seen significant advancement in research on AI & its potential to improve treatmnent for prostate cancer

Doctors and data scientists are working together to unlock the benefits of personalised medicine in treating the most common cancer found in men

22/12/2025

What do people want to know about prostate cancer and where do they find answers? https://ascopubs.org/doi/abs/10.1200/JCO.2025.43.16_suppl.e23073

20/12/2025

we're immensely proud of our gold-standard MDT

Explore the role of the prostate cancer MDT in shaping treatment decisions. Join our expert for an insightful discussion.

19/12/2025

Prostate cancer is the most common cancer among Canadian men. One in eight will be diagnosed in their lifetime; for many, the barrier to early detection isn’t lack of access to screening – it’s fear of what the diagnosis will mean for their lives afterward

For many men, prostate cancer is not just a question of survival. It is a question of how they will live afterward.

18/12/2025

Prostate cancer today is associated with a very high survival rate: 91%. This is why the quality of life of the almost half a million men living with the disease becomes a priority

Favo and Europa Uomo have set up the 'Courageous Dialogue' initiative: an invitation to patients and carers to share their experience openly

17/12/2025

"There is limited attention for health-related quality of life and functional status, although older patients often prioritize the latter"

Older patients are often deemed ineligible for clinical research, and many frequently-used endpoints and outcome measures are not as relevant for older patients for younger ones. This systematic review aimed to present an overview of outcomes used in clinical research regarding patients over the age...